Plasmodium berghei: sporozoites are sensitive to human serum but not susceptible host serum.

[1]  Syafruddin,et al.  Cyclical transmission of Plasmodium berghei (Coccidiida: plasmodiidae) by Anopheles omorii (Diptera: Culicidae). , 1992, Journal of medical entomology.

[2]  R. Sinden,et al.  The development of exo-erythrocytic schizonts of Plasmodium berghei in vitro from gamma-irradiated and non-irradiated sporozoites: a study using confocal laser scanning microscopy , 1991, Parasitology.

[3]  F. Marciano-cabral,et al.  Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis , 1989, Infection and immunity.

[4]  K. Joiner,et al.  Complement evasion by protozoa. , 1989, Experimental parasitology.

[5]  V. Nussenzweig,et al.  Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components , 1989, The Journal of experimental medicine.

[6]  K. Joiner,et al.  Toxoplasma gondii: mechanism of resistance to complement-mediated killing. , 1989, Journal of immunology.

[7]  清 上村,et al.  樹洞性オオモリハマダラカ Anopheles omorii の累代飼育法 , 1988 .

[8]  R. Sinden,et al.  The fate of the circumsporozoite antigens during the exoerythrocytic stage of Plasmodium berghei. , 1988, European journal of cell biology.

[9]  K. Joiner.  Complement evasion by bacteria and parasites. , 1988, Annual review of microbiology.

[10]  A. Sher,et al.  Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Fujita,et al.  Characterization of three monoclonal antibodies against C3 with selective specificities. , 1987, Immunology.

[12]  A. Sher,et al.  Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Carter,et al.  Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement. , 1986, Journal of immunology.

[14]  A. Sher,et al.  gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes , 1985, The Journal of experimental medicine.

[15]  A. Balber,et al.  Externally disposed membrane polypeptides of intact and protease-treated Trypanosoma lewisi correlated with sensitivity to alternate complement pathway-mediated lysis , 1983, Infection and immunity.

[16]  M. Lima,et al.  Susceptibility of insect-borne, metacyclic forms of Trypanosoma cruzi to antibody-mediated mechanisms of destruction. , 1983, The American journal of tropical medicine and hygiene.

[17]  D. Turner.  Effect of trypsin and neuraminidase on the infectivity of Plasmodium gallinaceum sporozoites. , 1983, Annals of tropical medicine and parasitology.

[18]  D. Fearon,et al.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. , 1982, Journal of immunology.

[19]  K. Austen,et al.  Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a. , 1981, Journal of immunology.

[20]  A. Sher,et al.  Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Oppenheim,et al.  Plasmodium berghei and Plasmodium knowlesi: serum binding to sporozoites. , 1980, Experimental parasitology.

[22]  V. Nussenzweig,et al.  Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. , 1980, Science.

[23]  R. Nussenzweig,et al.  Antibody-induced ultrastructural changes of malarial sporozoites. , 1976, Journal of immunology.

[24]  Z. Cohn,et al.  Studies on the selective lysis and purification of Trypanosoma cruzi , 1975, The Journal of experimental medicine.

[25]  J. Vanderberg.  Development of infectivity by the Plasmodium berghei sporozoite. , 1975, The Journal of parasitology.